Biochem/physiol Actions
CP-335963 is an aurora 2 kinase inhibitor, PDGF inhibitor, and anti-proliferative.
Other Notes
This compound was developed by Pfizer for Kinase Phosphatase Biology research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.
To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Sold for research purposes under agreement from Pfizer, Inc.
Pfizer is a registered trademark of Pfizer, Inc.
- UPC:
- 42294717
- Condition:
- New
- HazmatClass:
- No
- MPN:
- PZ0108-25MG
- CAS:
- 183322-18-1
akash.verma@cenmed.com
(732) 447-1115





